166 Views · 98 Downloads · ☆☆☆☆☆ 0.0

Stem cell technology to cure age-related macular degeneration (AMD)

PUBLISHED November 01, 2022 (DOI: https://doi.org/10.54985/peeref.2211p4104893)



Kruthica Jaganathan Geethalakshmi1 , Iyshwarya Bhaskar Kalarani1 , Ramakrishnan Veerabathiran1
  1. Chettinad Academy of Research and Education

Conference / event

Chettinad Academy of Research and Education, October 2022 (Chettinad Health City, India)

Poster summary

Age-related macular degeneration (AMD) is a disorder that affects the retinal pigment epithelium which is a multifunctional monolayer of hexagonal cells at the back of the eye. The loss of retinal pigment epithelium (RPE) cells in age-related macular degeneration (AMD) causes the demise of photoreceptors and everlasting blindness, RPE cell transplantation strives to cure or reverse vision loss by preventing the death of photoreceptor cells and the most prominent application is stem cell treatment in regenerative medicine. According to initial reports from clinical trials, transplanting RPE cells obtained from HPSCs can allow AMD patients to vision clear, as a proof-of-concept, RPE cell transplantation for treating other retinal degenerative diseases such as AMD, has long been demonstrated in human and animal studies involving primary RPE cells, although recent studies have concentrated on the transplantation of RPE cells made from human pluripotent stem cells (HPSC).


Macular degeneration, Photoreceptors, Retina, Stem cells, Genetics

Research areas



No data provided


No data provided

Supplemental files

No data provided

Additional information

Competing interests
No competing interests were disclosed.
Data availability statement
Data sharing not applicable to this poster as no datasets were generated or analyzed during the current study.
Creative Commons license
Copyright © 2022 Jaganathan Geethalakshmi et al. This is an open access work distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Jaganathan Geethalakshmi, K., Bhaskar Kalarani, I., Veerabathiran, R. Stem cell technology to cure age-related macular degeneration (AMD) [not peer reviewed]. Peeref 2022 (poster).
Copy citation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.


Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started